Disease Interception and the US National Cancer Moonshot

April 26, 2016
DIA

Develop. Innovate. Advance. DIA is the only global organization dedicated to bringing health care product development professionals together in a neutral environment to improve health and well-being throughout the world. - See more at:http://www.diaglobal.org/en/about-us#sthash.uT0zazfD.dpuf

April 26, 2016.

In the US, patients, caregivers and advocates, drug developers and the FDA have moved towards a patient-centered approach to drug development. The National Cancer Moonshot, a task force led by Vice President Joseph Biden, includes this patient-centric strategy in its agenda: Seeking to facilitate collaborations with researchers, doctors, philanthropies, patients, patient advocates, and biotechnology and pharmaceutical companies to accelerate the early detection and treatment of cancer, its goal is a decade’s worth of advances in five years.

Read more here.